Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The metabolic syndrome and cardiovascular risk in the British Regional Heart Study

International Journal of Obesity volume 32, pages S25–S29 (2008)Cite this article

Abstract

Objective:

To evaluate the metabolic syndrome as an overall risk assessment tool for cardiovascular disease (CVD) and diabetes in middle-aged British men.

Design:

Prospective study.

Subjects:

A total of 5128 men aged 40–59 years with no history of CVD or diabetes drawn from general practices in 24 British towns and followed up for 20 years.

Results:

The metabolic syndrome (National Cholesterol Expert Panel definition) is associated with a significant increase in risk of total CHD (myocardial infarction, angina or CHD death) (relative risk (RR), 95% CI: 1.57, 1.39–1.97), stroke (1.61, 95% CI: 1.26–2.06) and type 2 diabetes (3.57, 95% CI: 2.83–4.50) and is a far stronger predictor of diabetes than of total CHD and stroke in middle-aged men. The metabolic syndrome was inferior to the Framingham Risk Score in predicting total CHD or major CVD over 20 years (area under the curve (AUC) 0.58 vs 0.66 for both CHD and CVD; P<0.0001 for difference) but was superior in predicting diabetes (AUC 0.70 vs 0.60; P<0.001). However, absolute risk of developing CVD or diabetes over 20 years in those with three or more abnormalities was very high, ranging from 41.8% in those with three abnormalities to over a 50% chance in those with four of five abnormalities, comparable to the absolute incidence rates in the top 2 fifths of the Framingham distribution.

Conclusion:

While the initial aim to use the metabolic syndrome to improve risk prediction of CHD has been disappointing, the syndrome identifies patients at high risk of both diabetes and CVD who may derive benefit from lifestyle intervention.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Expert Panel on Detection, Evaluation and Treatment of High blood cholesterol in adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

    Article  Google Scholar 

  2. Alberti KG, Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.

    Article  CAS  Google Scholar 

  3. Balkau B, Charles MA . Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442–443.

    Article  CAS  Google Scholar 

  4. Galassi A, Reynolds K, He J . Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006; 119: 812–819.

    Article  CAS  Google Scholar 

  5. Garni AS, Witt BJ, Howard DE, Erwin PJ, Garni LA, Somers VK et al. Metabolic syndrome and risk of incident cardiovascular events and death. J Am Coll Cardiol 2007; 49: 403–414.

    Article  Google Scholar 

  6. Grundy SM, Brewer B, Cleeman JI, Smith SC, Lenfant C, for the Conference Participants. Definition of metabolic syndrome: report of the National Heart Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.

    Article  Google Scholar 

  7. Meigs J . Metabolic syndrome: in search of a clinical role. Diabetes Care 2004; 27: 2761–2763.

    Article  Google Scholar 

  8. Kohli P, Greenland P . Role of the metabolic syndrome in risk assessment for coronary heart disease. JAMA 2006; 295: 819–821.

    Article  CAS  Google Scholar 

  9. Grundy SM . Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr 2006; 83: 1248–1251.

    Article  CAS  Google Scholar 

  10. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association, European Association for the study of diabetes. The metabolic syndrome: time for a clinical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289–2304.

    Article  Google Scholar 

  11. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM . Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 2676–2681.

    Article  Google Scholar 

  12. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 385–390.

    Article  Google Scholar 

  13. Wannamethee SG, Shaper AG, Lennon L, Morris RW . Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke and type 2 diabetes. Arch Intern Med 2005; 165: 2644–2650.

    Article  Google Scholar 

  14. Lawlor DA, Smith GD, Ebrahim S . Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 2006; 49: 41–48.

    Article  CAS  Google Scholar 

  15. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J . The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007; 28: 857–864.

    Article  Google Scholar 

  16. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thomson AG . British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ 1981; 283: 179–186.

    Article  CAS  Google Scholar 

  17. Walker M, Shaper AG, Lennon L, Whincup PH . Twenty year follow-up of a cohort study based in general practices in 24 British towns. J Public Health Med 2000; 22: 479–485.

    Article  CAS  Google Scholar 

  18. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414–419.

    Article  CAS  Google Scholar 

  19. Eberly LE, Stamler J, Neaton JD, for the Multiple Risk factor Intervention Trial Research Group. Relation of triglyceride levels, fasting and non-fasting, to fatal and non-fatal coronary heart disease. Arch Intern Med 2003; 163: 1077–1083.

    Article  Google Scholar 

  20. Najarian RM, Sullivan LM, Kannel WB, Wilson PWF, D'Agostino RB, Wolf PA . Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke. Arch Intern Med 2006; 166: 106–111.

    Article  Google Scholar 

  21. Wilson PWF, D'Agostino RB, Parise H, Sullivan L, Meigs JB . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066–3072.

    Article  CAS  Google Scholar 

  22. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 100: 1245–1250.

    Article  Google Scholar 

  23. Ford ES . The metabolic syndrome and mortality from cardiovascular disease and all causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004; 173: 309–314.

    Article  CAS  Google Scholar 

  24. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327: 1238–1239.

    Article  Google Scholar 

  25. Anderson KM, Wilson PW, Odell PM, Kannel WB . An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356–362.

    Article  CAS  Google Scholar 

  26. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W et al., Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians. The Strong Heart Study. Diabetes Care 2003; 26: 861–867.

    Article  Google Scholar 

  27. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP . National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004; 110: 1251–1257.

    Article  Google Scholar 

  28. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.

    Article  Google Scholar 

  29. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC et al., Bruneck Study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Prospective data from the Bruneck Study. Diabetes Care 2003; 26: 1251–1257.

    Article  Google Scholar 

  30. Li C, Ford ES . Definition of the metabolic syndrome: what's new and what predicts risk. Metabolic Syndrome and Related Disorders 2006; 4: 237–251.

    Article  Google Scholar 

  31. Kannel WB . Coronary heart disease risk factors in the Elderly. Am J Geriatr Cardiol 2002; 11: 101–107.

    Article  Google Scholar 

  32. Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) 2005; 29: 1–19.

    Article  Google Scholar 

  33. Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F et al., for the ILSA Working Group. Metabolic syndrome, diabetes and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci 2006; 61: 505–510.

    Article  Google Scholar 

  34. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan DE et al., for the Health ABC Study. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006; 47: 1595–1602.

    Article  Google Scholar 

Download references

Acknowledgements

The British Regional Heart Study is a British Heart Foundation Research Group.

Author information

Authors and Affiliations

  1. Department of Primary Care and Population Science, Royal Free and University College Medical School, London, UK

    S G Wannamethee

Authors
  1. S G Wannamethee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S G Wannamethee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wannamethee, S. The metabolic syndrome and cardiovascular risk in the British Regional Heart Study. Int J Obes 32 (Suppl 2), S25–S29 (2008). https://doi.org/10.1038/ijo.2008.32

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2008.32

Keywords

This article is cited by

Search

Advanced search

Quick links